Åsa Grauman studies cancer patients' (acute myological leukemia) preferences and perspectives on individualized treatment using algorithms. The research is part of the multidisciplinary VR project MEET-AML, whose goal is to be able to tailor treatment for individual patients using an algorithm that identifies vulnerabilities in leukemia cells' metabolism using -omics data. The project also includes developing ways to integrate patients' preferences, what they want and their own balance between risk and benefit, in the individualized treatment. In her research, she uses preference studies where both qualitative and quantitative methods are included, to understand how people balance their interests and values.
Åsa is also involved in the EU project ENLIGHTENME which studies how urban lighting affects the population's health and well-being. Together with colleagues at CRB, Deborah Mascalzoni and Mirko Ancilotti, Åsa will study the ethical aspects of the project.
Åsa has a master's degree in public health science and has a doctorate in medical science from Uppsala University. Her PhD project was about how people perceive their risk of suffering from heart disease, how people are affected by cardiovascular risk information and their preferences of how risk information should be conveyed.
Phone: +46 18 471 62 44
Recently in media
We are investigating risk information from serval perspectives.
Managing genetic risk information
Research generates huge amounts of genetic information. How should we handle it? That is what we are trying to find out in a large international research project.
Cardiovascular risk information
Åsa Grauman will investigate how research participants perceive their personal risk for cardiovascular disease, and their perceptions on cardiovascular risk information.
Policyrekommendationer: Informera om risk för hjärt- och kärlsjukdomar
The publics’ perspective on cardiovascular risk information: Implications for practice
Communicating test results from a general health checkup: the public’s preferences from a discrete choice experiment survey
Part of Patient Related Outcome Measures, 2021.
Good general health and lack of family history influence the underestimation of cardiovascular risk: A cross sectional study
Part of European Journal of Cardiovascular Nursing, 2021.
Short-term mental distress in research participants after receiving cardiovascular risk information
Part of PLOS ONE, 2019.
Exploring research participants' perceptions of cardiovascular risk information-Room for improvement and empowerment
Part of Patient Education and Counseling, p. 1528-1534, 2019.
Informing about cardiovascular risk
Any health care interventions should be made after careful consideration of the benefits and risks for the individual. But experts and the general public sometimes have different views on what the benefit actually is. Understanding how the public perceives risk is important for designing the information correctly: to build on the individual's pre-understanding, to bridge knowledge gaps, and to correct inaccuracies. From a societal perspective, it is also important to ensure that health care efforts are equal. By examining which groups benefit from the efforts, they can be directed towards particularly vulnerable groups and individuals.
This policy brief contains Åsa Grauman's recommendations for how best to inform the public about the risk of cardiovascular disease.